Resources

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/28628235

Learn more
Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471489/

Learn more
Immunoadsorption therapy in autoimmune encephalitides February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772911/

Learn more
“Autoimmune Epilepsy”: Encephalitis with Autoantibodies for Epileptologists February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486416/

Learn more
From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time February 27, 2021

https://www.sciencedirect.com/science/article/pii/S156899721630163X

Learn more
Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy February 27, 2021

https://www.sciencedirect.com/science/article/pii/S002839081730196X?via%3Dihub

Learn more
Clinical characterization of autoimmune LGI1 antibody limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/26896820

Learn more
Clinical characterization of autoimmune encephalitis and psychosis February 27, 2021

https://www.sciencedirect.com/science/article/pii/S0010440X16304539?via%3Dihub

Learn more
Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/27037228

Learn more
Adaptive immunity is the key to the understanding of autoimmune and paraneoplastic inflammatory central nervous system disorders February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362596/

Learn more